Harris Teeter on Monday announced its Plaza Midwood location in Charlotte, N.C., is now officially recognized as a LEED-certified project by the U.S. Green Building Council and verified by the Green Building Certification Institute.
In an effort to help ensure clean waterways, Illinois Gov. Pat Quinn has signed legislation to make Illinois the first state in the nation to ban the manufacture and sale of personal care products containing synthetic plastic microbeads.
Joel Anderson, president and chief executive officer of Walmart.com, has departed the online giant to assume the role of president at Five Below, a retailer that targets pre-teens and teens with trendy, extreme-value merchandise, according to a Five Below press release issued Tuesday morning.
Beauty company L'Oréal Paris has applied image recognition technology to target product ads based on the hair color identified in photos of faces for its Ombré campaign, which is now live on GumGum's in-image advertising platform.
Market6, a provider of web-based retail analytic applications, on Tuesday announced the introduction of Market6 Vantage, a suite of retail analytic applications that automate and simplify joint business planning and retailer/supplier collaboration.
New York Gov. Andrew Cuomo last week announced an agreement between New York State and GW Pharmaceuticals to develop clinical trials using an active ingredient derived from the marijuana plant to help treat children diagnosed with epilepsy who suffer from seizures and other medical complications.
Ohio Gov. John Kasich on Monday signed executive order 2014-04K authorizing licensed pharmacists to administer the measles, mumps, and rubella (MMR) vaccine to individuals 18 years and older in order to provide those adults who have not yet received this vaccination with additional opportunities to obtain the MMR vaccine.
As many as 40% of U.S. narcotic prescriptions in 2011-2012 were written by only 5% of opioid prescribers, according to a study Express Scripts presented Monday at AcademyHealth's annual research meeting.
A recently approved drug might make infusions for hemophiliacs fewer and further between. The Food and Drug Administration approved Biogen Idec's Eloctate, which clinical trials have shown works to treat bleeding episodes and to increase the time between prophylactic blood infusions for those with hemophilia A.